Tumor-infiltrating M2-type macrophages then inhibit the antigen-presenting ability of dendritic cells (DCs) by producing IL-10 and prevent DCs from activating CTLs, thereby causing dysfunction of DCs in the TME (54). Here, IL10 is linked to neoplasm.